Experiences with
Lung transplant4,790 public posts
Want to take advantage of all our features? Just log in!
or
1st patient enrolled in global Phase 2 trial of daxdilimab for lupus
Study to test safety, efficacy of Horizon's lupus nephritis treatment
by Steve Bryson PhD | May 18, 2023
A woman speaks with a megaphone in this announcement illustration.
A Phase 2 trial evaluating the safety and efficacy of daxdilimab, a potentially first-in-class treatment for people with active
FDA Program discussion with leaders from patient advocacy groups.
When: Jun 8, 2023 2:30 PM- 4:00 PM Eastern Time (US and Canada)
Topic: FDA Patient Listening Session – Non-Small Cell Lung Cancer Patient Advocacy Groups
Join us for a discussion with patient advocacy groups, patients, and caregivers, who will share challenges and opportunities as they advocate for
Join Us! Tomorrow, May 9th, Gathering HOPE Community Social
Hello!
For those of you who know me and to those of you I may not have spoken with or met yet, I am Michele Zeh, Manager of the Lung Cancer Living Room Series and I am excited to invite you to our monthly Gathering HOPE Social hosted on our ZOOM link. Tomorrow, May 9th, at 5pm PT/8pm ET. At this meeting